Placenta
Volume 29, Issue 5 , Pages 413-421 , May 2008

Altered Uterine Perfusion is Involved in Fetal Outcome of Diabetic Rats

  • S. Zabihi

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Medical Cell Biology, Uppsala University, Biomedical Center, P.O. Box 571, SE-751 23 Uppsala, Sweden. Tel.: +46 18 471 4033; fax: +46 18 550 720.
    • ,
  • P. Wentzel
    • ,
  • U.J. Eriksson

,Accepted 11 February 2008.

References 

  1. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61:85–95
  2. Casson I, Clarke C, Howard C, McKendrick O, Pennycook S, Pharoah P, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ. 1997;315:275–278
  3. Greene MF. Diabetic embryopathy 2001: moving beyond the “diabetic milieu”. Teratology. 2001;63:116–118
  4. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med. 1971;7:73–82
  5. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes. 1979;28:292–293
  6. Leslie RDG, Pyke DA, John PN, White JM. Hemoglobin A1 in diabetic pregnancy. Lancet. 1978;ii:958–959
  7. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331–1334
  8. Ramos-Arroyo M, Rodriguez-Pinilla E, Cordero J. Maternal diabetes: the risk for specific birth defects. Eur J Epidemiol. 1992;8:503–508
  9. Ziereisen F, Courtens W, Clercx A, Perlmutter N. Maternal diabetes and fetal malformations: a case associating cardiovascular, facial and skeletal malformations. Pediatr Radiol. 1997;27:945–947
  10. New D, Coppola P. Development of a placental blood circulation in rat embryos in vitro. J Embryol exp Morph. 1977;37:227–235
  11. Forsberg H, Eriksson U, Melefors O, Welsh N. Beta-hydroxybutyrate increases reactive oxygen species in late but not in early postimplantation embryonic cells in vitro. Diabetes. 1998;47:255–262
  12. Hagay Z, Weiss Y, Zusman I, Peled-Kamar M, Reece E, Eriksson U, et al. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol. 1995;173:1036–1041
  13. Horton WJ, Sadler T. Effects of maternal diabetes on early embryogenesis. Alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate. Diabetes. 1983;32:610–616
  14. Moore D, Stanisstreet M, Clarke C. Morphological and physiological effects of beta-hydroxybutyrate on rat embryos grown in vitro at different stages. Teratology. 1989;40:237–251
  15. Styrud J, Thunberg L, Nybacka O, Eriksson UJ. Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res. 1995;37:343–353
  16. Pinter E, Reece EA, Leranth CS, Sanyal MK, Hobbins JC, Mahoney MJ, et al. Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions. Teratology. 1986;33:73–84
  17. Pinter E, Reece EA, Leranth CZ, Garcia-Segura M, Hobbins JC, Mahoney MJ. Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol. 1986;155:691–702
  18. Pampfer S, de Hertogh R, Vanderheyden I, Michiels B, Vercheval M. Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes. 1990;39:471–476
  19. Cederberg J, Eriksson UJ. Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology. 1997;56:350–357
  20. Sivan E, Lee Y, Wu Y, Reece E. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology. 1997;56:343–349
  21. Pampfer S, Vanderheyden I, McCracken J, Vesela J, De Hertogh R. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. Development. 1997;124:4827–4836
  22. Moley K, Chi M, Knudson C, Korsmeyer S, Mueckler M. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med. 1998;4:1421–1424
  23. Fine E, Horal M, Chang T, Fortin G, Loeken M. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes. 1999;48:2454–2462
  24. Cederberg J, Galli J, Luthman H, Eriksson UJ. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes. 2000;49:101–107
  25. Chi M, Pingsterhaus J, Carayannopoulos M, Moley K. Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J Biol Chem. 2000;275:40252–40257
  26. Pinter E, Haigh J, Nagy A, Madri JA. Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol. 2001;158:1199–1206
  27. Sun F, Akazawa S, Sugahara K, Kamihira S, Kawasaki E, Eguchi K, et al. Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and Bcl-2. Arch Histol Cytol. 2002;65:145–157
  28. Madri JA, Enciso J, Pinter E. Maternal diabetes: effects on embryonic vascular development—a vascular endothelial growth factor-A-mediated process. Pediatr Dev Pathol. 2003;6:334–341
  29. Gareskog M, Cederberg J, Eriksson UJ, Wentzel P. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos. Reprod Toxicol. 2007;23:63–74
  30. Nienartowicz A, Link S, Moll W. Adaptation of the uterine arcade in rats to pregnancy. HJ Dev Physiol. 1989;12:101–108
  31. Vom Saal F, Dhar M. Blood flow in the uterine loop artery and loop vein is bidirectional in the mouse: implications for transport of steroids between fetuses. Physiol Behav. 1992;52:163–171
  32. Wentzel P, Jansson L, Eriksson U. Diabetes in pregnancy: uterine blood flow and embryonic development in the rat. Pediatr Res. 1995;38:598–606
  33. Even M, Laughlin M, Krause G, vom Saal F. Differences in blood flow to uterine segments and placentae in relation to sex, intrauterine location and side in pregnant rats. J Reprod Fertil. 1994;102:245–252
  34. Gibson W, Roche P. Blood flow in the ovary and oviduct of rats after sympathetic denervation. J Reprod Fertil. 1986;78:193–199
  35. Lipshitz J, Ahokas R, Broyles K, Anderson G. Effect of hexoprenaline on uteroplacental blood flow in the pregnant rat. Am J Obstet Gynecol. 1986;154:310–314
  36. Tolins J, Shultz P, Raij L, Brown D, Mauer SM. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol. 1993;265:F886–F895
  37. Hill M, Larkins R. Alterations in distribution of cardiac output in experimental diabetes in rats. Am J Physiol. 1989;257:H571–H580
  38. Hill M, Larkins R. Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am J Physiol. 1989;257:H1438–H1445
  39. Eriksson UJ. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology. 1988;37:365–374
  40. Eriksson UJ, Dahlstrom E, Larsson KS, Hellerstrom C. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes. 1982;31:1–6
  41. Garris D. Intrauterine growth of the guinea pig fetal-placental unit throughout pregnancy: regulation by utero-placental blood flow. Teratology. 1984;29:93–99
  42. Franklin J, Brent R. Interruption of uterine blood flow: a new technique for the production of congenital malformations. Comparison of the eighth, ninth, and tenth days of gestation. Surg Forum. 1960;11:415–416
  43. Kuzmina I, Hubina-Vakulik G, Burton G. Placental morphometry and Doppler flow velocimetry in cases of chronic human fetal hypoxia. Eur J Obstet Gynecol Reprod Biol. 2005;120:139–145
  44. Pietryga M, Brazert J, Wender-Oegowska E, Biczysko R, Dubiel M, Gudmundsson S. Abnormal uterine Doppler is related to vasculopathy in pregestational diabetes mellitus. Circulation. 2005;112:2496–2500
  45. Arnush M, Scarim A, Heitmeier M, Kelly C, Corbett J. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol. 1998;160:2684–2691
  46. Ballian N, Brunicardi F. Islet vasculature as a regulator of endocrine pancreas function. World J Surg. 2007;31:705–714
  47. Olof P, Hellberg A, Kallskog O, Wolgast M. Red cell trapping and postischemic renal blood flow. Differences between the cortex, outer and inner medulla. Kidney Int. 1991;40:625–631
  48. Eriksson U, Borg L, Hagay Z, Groner Y. Increased superoxide dismutase (SOD) activity in embryos of transgenic mice protects from the teratogenic effects of a diabetic environment. Diabetes. 1993;42:85A
  49. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang H, Reed J. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol. 1994;145:1323–1336
  50. Miyashita T, Harigai M, Hanada M, Reed J. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 1994;54:3131–3135
  51. Sharova L, Sura P, Smith B, Gogal RJ, Sharov A, Ward D, et al. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology. 2000;62:420–428
  52. Galasso G, Schiekofer S, Sato K, Shibata R, Handy D, Ouchi N, et al. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res. 2006;98:254–261
  53. Pani L, Horal M, Loeken M. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev. 2002;16:676–680
  54. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes. 1997;46:1189–1197

PII: S0143-4004(08)00061-1

doi: 10.1016/j.placenta.2008.02.005

Placenta
Volume 29, Issue 5 , Pages 413-421 , May 2008

Article Tools

* Image Usage & Resolution